Find the Perfect Plan for Your Investment Journey
Last Price
52 Week Range
$0.80 - $3.20
Next Earnings Date
May 21 2025
Next Earnings Date
May 21 2025
Last Price
Market Cap | $48.48M |
EV | $33.48M |
Shares Outstanding | 41.08M |
Beta | -1.14 |
Analyst Rating | BUY |
Analyst Target Price | $8.00 |
P/E 2024E | - |
P/Revenue 2024E | - |
Revenue | - |
EPS | -75.30% |
Operating Cash Flow | -120.40% |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2024E | - |
Net Profit Margin 2024E | - |
ROE 2024E | - |
ROCE 2023 | -91.42% |
DPS 2024E | - |
Payout Ratio 2024E | - |
Div. Yield 2024E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Anebulo Pharmaceuticals, Inc.
ANEB
Sector
Healthcare
Industry
Biotechnology
CEO
Cunningham, Richard
Employees
3
Website
www.anebulo.comIPO Date
2021-05-07
Headquarters
1017 Ranch Road 620 South, Suite 107, Lakeway, Texas, 78734, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved